Mira Pharmaceuticals, Inc.
www.mira1a.comMIRA1a is being developed as the first prescription drug to target the CB1 and CB2 receptors for chronic pain and anxiety without the impurities of marijuana or its side effects, such as increased appetite and paranoia.
Read more
MIRA1a is being developed as the first prescription drug to target the CB1 and CB2 receptors for chronic pain and anxiety without the impurities of marijuana or its side effects, such as increased appetite and paranoia.
Read more
Country
State
Maryland
City (Headquarters)
Baltimore
Industry
Employees
1-10
Founded
2022
Social
Employees statistics
View all employeesPotential Decision Makers
Mira1A Therapeutics , Inc.
Email ****** @****.comPhone (***) ****-****
Reach decision makers at Mira Pharmaceuticals, Inc.
Free credits every month!
Mira Pharmaceuticals, Inc. FAQ
Baltimore, United States
Pharmaceutical Manufacturing
We'll help you understand if Lusha can solve your business needs.
